This week we welcome Dr. Adrienne Stevens, the Managing Director of Cochrane Canada. Cochrane is a global leader in the production of high quality SR, and have recently also started exploring the field of Rapid Reviews. Dr. Stevens expands on the differences between rapid reviews and systematic reviews, as well as the many ways that Cochrane is doing its part in combatting COVID-19 by continuing to promote evidence-informed health decision making. Not only have they released recommendations on rapid review methods to help investigators maintain high quality research, but they have also launched a recommendations map that is essentially a one-stop shop for all information regarding COVID. It launches today, Monday December 14th, and I’d highly recommend that this becomes your go-to for any questions you may have. It is both easy to use and understand for anyone, whether you are healthcare or not.
COVID19 Recommendations Map
Guidance for Conducting a High-Quality Rapid Review